๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Mumbai
Clinical trial register · India

Clinical Trials in Mumbai

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca37 Tata Memorial Centre32 Tata Memorial Hospital22 Novo Nordisk A/S12 Bristol-Myers Squibb11
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
259 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Active, closed
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421Neoplasms
Pfizer
Phase 3
841
Mumbai, Pune, Thane, New Delhi, Jaipur
2020-12-21
Active, closed
A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung Cancer
NCT04351555Non-Small Cell Lung Cancer
AstraZeneca
Phase 3
358
Mumbai, Namakkal, New Delhi, Varanasi
2020-12-16
Recruiting
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
NCT05236946Asymptomatic Brain Metastases, Driver Mutation Positive Non-small Cell Lung Cancer
Tata Memorial Hospital
Phase 3
190
Mumbai
2020-11-10
Active, closed
A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions
NCT04538664Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 3
308
Hyderabad, Kolkata, Mumbai, Nashik, New Delhi, Pune
2020-10-13
Active, closed
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
NCT04529772Diffuse Large B-Cell Lymphoma
Acerta Pharma BV
Phase 3
611
Bangalore, Delhi, Kochi, Mumbai, Nashik, Pune
2020-10-08
Active, closed
A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT04487080Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 3
1,074
Hyderabad, Kolkata, Mumbai, Nashik, Pune
2020-09-30
Active, closed
A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC
NCT04606771Non-Small Cell Lung Cancer
AstraZeneca
Phase 2
30
Delhi, Mumbai
2020-09-28
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
NCT04462770Dravet Syndrome
Epygenix
Phase 3
150
Hyderabad, Surat, Belagavi, Bengaluru, Kochi, Pune, Mumbai, Nagpur
2020-09-15
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
CanariaBio Inc.
Phase 3
615
Bangalore, Bengaluru, Delhi, Mohali, Mumbai, Noida, Pune
2020-08-25
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca
Phase 2
477
Delhi, Gurgaon, Kolkata, Mumbai
2020-08-18
Recruiting
Focal Radiotherapy Plus Low Dose Craniospinal Irradiation Followed by Adjuvant Chemotherapy in WNT Medulloblastoma.
NCT04474964Medulloblastoma, WNT-activated
Tata Memorial Centre
Not applicable
30
Mumbai
2020-08-13
Recruiting
Palliative Radiation for Advanced Cervical Cancer
NCT03997110Cervical Cancer
Tata Memorial Hospital
Not applicable
230
Mumbai
2020-06-19
Active, closed
KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT03946202Breast Cancer
Institute of Cancer Research, United Kingdom
Phase 2
184
Trivandrum, Vellore, Kolkata, Mumbai
2020-06-16
Active, closed
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer
NCT04269200Endometrial Neoplasms
AstraZeneca
Phase 3
805
Hisar, Mumbai
2020-05-05
Recruiting
EORTC Metastatic Breast Cancer Module Development
NCT07806266Metastatic Beast Cancer
University of Leeds
Observational
568
Mumbai
2020-05-01
Recruiting
Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC
NCT05278052Oligometastatic Disease, Metastatic Non Small Cell Lung Cancer
Tata Memorial Hospital
Phase 3
190
Mumbai
2020-04-20
Active, closed
Personal Health Train for Radiation Oncology in India and The Netherlands
NCT04655469Head and Neck Carcinoma
Maastricht Radiation Oncology
Observational
2,000
Bengaluru, Mumbai
2020-04-10
Recruiting
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
NCT04250064DIPG
Tata Memorial Centre
Phase 2
40
Mumbai
2020-02-04
Recruiting
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
NCT04638790Hodgkin Lymphoma, Adult
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia
Phase 3
300
Mumbai
2020-02-01
Recruiting
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NCT04057209Glottis Tumor, Larynx Cancer
Olgun Elicin
Not applicable
34
Mumbai
2019-11-20
Recruiting
Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC
NCT05277844Oligometastatic Disease, Non-small Cell Lung Cancer, Driver Mutation
Tata Memorial Hospital
Phase 2
106
Mumbai
2019-11-11
Recruiting
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (ฮฒ)-Thalassemia
NCT04143724Beta-Thalassemia
Celgene
Phase 2
99
Hyderabad, Mumbai, Nagpur, Noida, Kolkata, Vellore
2019-11-07
Recruiting
PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)
NCT07185672Neuroendocrine Neoplasia's (NENs), Neuroendocrine Tumor GEP Grade 1-3, Neuroendocrine Gastroenteropancreatic Tumour
Tata Memorial Hospital
Phase 3
162
Mumbai, Navi Mumbai
2019-08-07
Active, closed
Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC
NCT03997123Triple Negative Breast Neoplasms
AstraZeneca
Phase 3
923
Bangalore, Gurgaon, Kolkata, Mumbai, Mysuru, Nagpur, Nashik, New Delhi
2019-06-25
Active, closed
ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy
NCT03769506Head and Neck Cancer
Rakuten Medical, Inc.
Phase 3
135
Vadodara, Bangalore, Kochi, Chennai, Hyderabad, Kolkata, Mumbai
2019-05-09
Rows per page Showing 201–225 of 259
Previous 7 8 9 10 11 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/mumbai

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.